Stock listing
NASDAQ:TBRA Tobira Therapeutics Inc Stock
Follow Tobira Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:TBRA
$42.09 USD
Close on Oct 31, 2016 · No longer trades
- Lowest – highest close
- $3.89 – $121.50 USDSince Aug 22, 2013 · lowest Aug 8, 2016 · highest Mar 18, 2014
Delisted NASDAQ:TBRA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TBRA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Pierre Legault Other companies: Syndax Pharmaceuticals, Inc. (Director · Since at least Jan 4, 2017); Bicycle Therapeutics PLC (Director · May 22, 2019 – Jan 2, 2025 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Mar 29, 2021 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Mar 26, 2018 · Past); NPS Pharmaceuticals Inc (Director · Nov 3, 2014 – Feb 21, 2015 · Past); NephroGenex Inc (Chief Executive Officer, Director · Feb 10, 2014 – Nov 10, 2015 · Past); Forest Laboratories Inc (Director · Aug 15, 2013 – Jul 1, 2014 · Past) | Director · Nov 18, 2013 – Nov 1, 2016 · Past |
| Jesse I Treu Other companies: CoLucid Pharmaceuticals Inc (Director · May 5, 2015 – May 11, 2015 · Past); Aldeyra Therapeutics, Inc. (Director · May 1, 2014 – Jun 9, 2020 · Past); Tandem Diabetes Care, Inc. (Director · Nov 13, 2013 – Nov 15, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Feb 28, 2019 · Past); Somaxon Pharmaceuticals Inc (Director · Mar 3, 2010 – Jun 9, 2010 · Past) | Director · Aug 21, 2013 – Jan 1, 2015 · Past |
| Carol Brosgart Other companies: Cocrystal Pharma, Inc. (Director · Since at least Aug 12, 2026); Galmed Pharmaceuticals Ltd. (Director · Since at least Mar 18, 2026); Mirum Pharmaceuticals, Inc. (Director · Jun 4, 2021 – Jun 2, 2022 · Past); Lunai Bioworks Inc. (Director · Dec 27, 2019 – Jun 25, 2024 · Past) | Director · Jul 9, 2015 – Nov 1, 2016 · Past |
| Dennis Podlesak Other companies: Syndax Pharmaceuticals, Inc. (Director · Since at least Mar 2, 2016); Avanir Pharmaceuticals Inc (Director · Feb 19, 2009 – Feb 12, 2014 · Past) | Director · Aug 21, 2013 – Nov 1, 2016 · Past |
| Raphael Wisniewski Other companies: Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Jan 17, 2020 · Past) | Director · Aug 21, 2013 – Jan 1, 2014 · Past |
| Christopher Paul Rusconi | Chief Scientific Officer · Aug 21, 2013 – Jan 1, 2014 · Past |
Log in to ask 6ix AI your own questions about Tobira Therapeutics Inc.